Search for: "Pharms v. U.s.*" Results 241 - 260 of 384
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
I/P Engine, Inc. v. AOL Inc.: Obviousness Findings Before a Jury
11 Mar 2015, 9:10 pm
Teva Pharms. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
Layers of Doctrine with a Faulty Claim Construction at the Core
21 May 2018, 7:22 pm by Dennis Crouch
” Ariad Pharm., Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
District Court Decision Sidesteps 30-Month Stay Tolling Issue; Denies Patent Infringement Litigation Stay
19 Apr 2010, 1:34 pm by FDABlog HPM
Cir. 2009) and Andrx Pharm., Inc. v. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Higher and Higher (Into the Fire): Jacobus Appeals Orphan Drug Case to SCOTUS
20 Apr 2022, 8:29 pm by Kurt R. Karst
”  Citing Sigma-Tau Pharms., Inc. v. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
In IN RE: AFFINITY LABS OF TEXAS, LLC, case, CAFC emphasizes that estoppel provisions of pre-AIA section 317(b) are CLAIM-CENTRIC and PARTY-CENTRIC
5 May 2017, 11:24 am by Lawrence B. Ebert
Corp. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC: presumption of irreparable harm is jettisoned
12 Oct 2011, 8:31 am by Lawrence B. Ebert
Prods. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Federal Circuit Vacates Rilutek Decision, Remands Case Between Impax and Aventis to District Court
6 Dec 2006, 8:43 pm
Aventis Pharms., 333 F. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Divided Federal Circuit Panel Strikes Down Galderma’s Patents as Obvious—in Shifting the Burden of Production Regarding Secondary Considerations to the Patentee, Did the Majority in Fact Shift the Burden of Persuasion, Too?
18 Dec 2013, 9:00 pm by Aaron Barkoff
Caraco Pharm. [read post]
Orange Book Blog - http://www.orangebookblog.com/
U.S. District Court Adopts Expansive Definition of aBLA “Submitter”
20 Sep 2021, 1:23 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and Monica Ortel (Ropes & Gray LLP)
Alembic Pharms. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
U.S. District Court Adopts Expansive Definition of aBLA “Submitter”
20 Sep 2021, 1:23 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and Monica Ortel (Ropes & Gray LLP)
Alembic Pharms. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Tribal Sovereign Immunity Denied, Will State Immunity Hold at the PTAB?
22 Jul 2018, 7:39 pm by Scott McKeown
Regis Mohawk Tribe v Mylan Pharm., Inc. [read post]
Patents Post-Grant - http://www.patentspostgrant.com
Wrongful foreclosure claim in Texas
19 May 2017, 12:23 pm by Wolfgang Demino
Co. v. [read post]
Texas Causes of Action Blawg - http://causeofactionelements.blogspot.com/
ED Wisc discusses "a sandbox for gratuitous sniping" in case about lithium-ion batteries used in power tools
23 Sep 2017, 12:39 pm by Lawrence B. Ebert
See Teva Pharms. [read post]
IPBiz - http://ipbiz.blogspot.com/
Purdue Pharma loses at CAFC on appeals of IPR2014-377,378, and 379
24 Mar 2016, 10:43 am by Lawrence B. Ebert
See PAR Pharm., Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC addresses venue, personal jurisdiction in Heartland case
29 Apr 2016, 9:37 am by Lawrence B. Ebert
Beverly Hills Fan,21 F.3d at 1565; see also Acorda Therapeutics Inc. v.Mylan Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
Merial wins over Intervert at CAFC: pigs and things
4 Aug 2010, 9:20 am by Lawrence B. Ebert
Chugai Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
In Bid to Curtail 180-day Exclusivity, FDA Alters Longstanding Practice and Newly Declares that Converted OTC Products Are Not “Listed Drugs”
21 Jun 2022, 12:18 am by Kurt R. Karst
  See, e.g., Breckenridge Pharms., Inc. v. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Inherent
13 Aug 2010, 12:46 pm
See King Pharms., Inc., 593 F. [read post]
Patent Prospector - http://www.patenthawk.com/blog/
Is the Advance Meaningful?
16 Apr 2022, 2:49 pm by Dennis Crouch
” Teva Pharms. [read post]
Patently-O - https://patentlyo.com
NAD advises DirecTV to change Rob Lowe ads
9 Apr 2015, 9:33 am by Katharyn Grant (US)
”); Johnson & Johnson-Merck Consumer Pharm. [read post]
The Brand Protection Blog - http://www.thebrandprotectionblog.com